JAM
KYNB

Jupiter Asset Management’s Kyntra Bio KYNB Stock Holding History

Jupiter Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,121
Closed -$3.83M – 590
2020
Q4 		$3.83M Buy
4,121
+2,684
+187% +$2.82M 0.04% 353
2020
Q3 		$1.48M Buy
+1,437
New +$1.55M 0.02% 434

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jupiter Asset Management's KYNB Position: Q1 2021 in Review

Jupiter Asset Management sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 4,121 shares — an estimated $3.83M sold.

Jupiter Asset Management first reported a position in KYNB in Q3 2020 and held it in 2 quarters. The position peaked at $3.83M in Q4 2020. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Jupiter Asset Management reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
  • Jupiter Asset Management sold 4,121 Kyntra Bio shares in Q1 2021, an estimated $3.83M.
  • Jupiter Asset Management first reported a position in Kyntra Bio in Q3 2020 and held it in 2 quarters.
  • Jupiter Asset Management's Kyntra Bio position peaked at $3.83M in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Jupiter Asset Management's 13F filing for Q1 2021, filed 12 May 2021.